My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 255

    1.

    Is there enough evidence to support use of N-acetylcysteine in contrast-induced nephropathy?

    Trivedi H.

    Ann Intern Med. 2008 Aug 5;149(3):213; author reply 215-6. No abstract available. PMID: 18678853 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Is there enough evidence to support use of N-acetylcysteine in contrast-induced nephropathy?

    Berwanger O.

    Ann Intern Med. 2008 Aug 5;149(3):215; author reply 215-6. No abstract available. Erratum in: Ann Intern Med. 2008 Oct 7;149(7):519. PMID: 18678855 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Is there enough evidence to support use of N-acetylcysteine in contrast-induced nephropathy?

    Ferrante G, Locca D, Barlis P.

    Ann Intern Med. 2008 Aug 5;149(3):214-5; author reply 215-6. No abstract available. PMID: 18678854 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Is there enough evidence to support use of N-acetylcysteine in contrast-induced nephropathy?

    Gonzales DA, Star RA, Kern SJ, Natanson C, Danner RL.

    Ann Intern Med. 2008 Aug 5;149(3):213-4; author reply 215-6. No abstract available. PMID: 18678852 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Review of contrast-induced nephropathy and current use of N-acetylcysteine (NAC).

    Anwar M, Ledger S.

    CANNT J. 2005 Jan-Mar;15(1):33-8,quiz 38-9. Review. No abstract available. PMID: 15909775 [PubMed - indexed for MEDLINE]Related articles

    6.

    N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials.

    Stenstrom DA, Muldoon LL, Armijo-Medina H, Watnick S, Doolittle ND, Kaufman JA, Peterson DR, Bubalo J, Neuwelt EA.

    J Vasc Interv Radiol. 2008 Mar;19(3):309-18. Review.PMID: 18295688 [PubMed - indexed for MEDLINE]Related articles

    7.

    Interactions between serum creatinine, volume status, N-acetylcysteine, and contrast-induced nephropathy.

    Toprak O.

    Ren Fail. 2006;28(3):265-6.PMID: 16703801 [PubMed - indexed for MEDLINE]Related articles

    8.

    Does the prophylactic use of N-acetylcysteine prevent contrast nephropathy in patients with renal insufficiency?

    Ma IW, Hladunewich M.

    CMAJ. 2004 Apr 13;170(8):1231. No abstract available. PMID: 15078844 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    [The use of acetylcysteine for preventing contrast-induced nephropathy]

    Schaad N, Barghouth G.

    Rev Med Suisse. 2005 Jun 22;1(25):1693-6. Review. French. No abstract available. PMID: 16117036 [PubMed - indexed for MEDLINE]Related articles

    10.

    Sodium bicarbonate, N-acetylcysteine, and saline for the prevention of contrast-induced nephropathy.

    Bouzas-Mosquera A, Recio-Mayoral A.

    Am Heart J. 2008 Apr;155(4):e31. Epub 2008 Mar 6. No abstract available. PMID: 18371455 [PubMed - indexed for MEDLINE]Related articles

    11.

    N-acetylcysteine and contrast-induced nephropathy.

    Ritz E.

    N Engl J Med. 2006 Oct 5;355(14):1499; author reply 1499-500. No abstract available. PMID: 17024738 [PubMed - indexed for MEDLINE]Related articles

    12.

    Prevention of contrast-induced nephropathy in vascular surgery patients.

    Lawlor DK, Moist L, DeRose G, Harris KA, Lovell MB, Kribs SW, Elliot J, Forbes TL.

    Ann Vasc Surg. 2007 Sep;21(5):593-7.PMID: 17823041 [PubMed - indexed for MEDLINE]Related articles

    13.

    Preventing nephropathy induced by contrast medium.

    Tepel M.

    N Engl J Med. 2006 Apr 27;354(17):1853-5; author reply 1853-5. No abstract available. PMID: 16642596 [PubMed - indexed for MEDLINE]Related articles

    14.

    N-acetylcysteine and/or theophylline as a preventive measure for contrast agent induced nephropathy: we should use better markers for detection of renal function.

    Schultz MJ.

    Radiology. 2007 Dec;245(3):918-9; author reply 918-9. No abstract available. PMID: 18024462 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy.

    Guru V, Fremes SE.

    Clin Nephrol. 2004 Aug;62(2):77-83. Review.PMID: 15356963 [PubMed - indexed for MEDLINE]Related articles

    16.

    Contrast-induced nephropathy: a clinical and evidence-based approach.

    Tepel M, Aspelin P, Lameire N.

    Circulation. 2006 Apr 11;113(14):1799-806. Review. No abstract available. PMID: 16606801 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy: a review.

    Walker PD, Brokering KL, Theobald JC.

    Pharmacotherapy. 2003 Dec;23(12):1617-26. Review.PMID: 14695041 [PubMed - indexed for MEDLINE]Related articles

    18.

    Has acetylcysteine use changed the incidence of contrast nephropathy in hospitalized patients? A before-after study.

    Shah SJ, Hsu CY.

    Am J Med. 2004 Dec 15;117(12):948-52. No abstract available. PMID: 15629734 [PubMed - indexed for MEDLINE]Related articles

    19.

    Prevention of contrast-induced renal dysfunction by N-acetylcysteine. Truth or myth?

    Billinger M, Hess OM, Meier B.

    Eur Heart J. 2004 Feb;25(3):188-9. No abstract available. PMID: 14972417 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Investigating the volume status before contrast nephropathy studies.

    Toprak O, Cirit M.

    Nephrol Dial Transplant. 2005 Feb;20(2):464; author reply 464-6. No abstract available. PMID: 15673702 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity